Join the 19th World Conference on Midwifery, Nursing & Primary Health Care 2026
📅Dates: June 08-09 2026
📍Venue: Renaissance London Heathrow Hotel
🔗Website: midwiferyconference.com

#midwifery #nursing #primary #pharmaceuticalcompanies #inovineconferences

What values drive companies in the pharmaceutical market? Explore the key orientation directions shaping their strategies! doi.org/10.1007/978-...
#values #openscience #science #pharmaceuticalcompanies

What values drive companies in the pharmaceutical market? Explore the key orientation directions shaping their strategies! doi.org/10.1007/978-...
#values #openscience #science #pharmaceuticalcompanies

Vveinhardt, J., Foktas, P. (2021). Values of Companies Operating in the Pharmaceutical Market: Orientation Directions. In: Bilgin, M.H., Danis, H., Demir, E. (eds) Eurasian Business and Economics Perspectives. Eurasian Studies in Business and Economics, vol 18. Springer, Cham. https://doi.org/10.1007/978-3-030-71869-5_20 In this study, the authors seek an answer to the following problematic question: what are the values of the companies operating in the pharmaceutical market and how are they oriented: inward, that is, economic indicators of the company, or outward, where are the benefits of the social context highlighted? Therefore, the purpose of this study is the identification of values of companies operating in the pharmaceutical market, establishing the most frequently published/congruent values, and grouping them according to the chosen classification, to distinguish directions of value orientation. For the purposes of this study, 50 largest pharmaceutical companies operating in the Lithuanian market, generating 80% of all money circulating in the Lithuanian pharmaceutical sector, were selected.

An endlessly fascinating topic of values, many of which still go unnoticed in current research. I invite you to dive into the article for more insights: doi.org/10.1007/978-...
#values #openscience #science #pharmaceuticalcompanies

Cite this paper Vveinhardt, J., Foktas, P. (2021). Values of Companies Operating in the Pharmaceutical Market: Orientation Directions. In: Bilgin, M.H., Danis, H., Demir, E. (eds) Eurasian Business and Economics Perspectives. Eurasian Studies in Business and Economics, vol 18. Springer, Cham. https://doi.org/10.1007/978-3-030-71869-5_20 In this study, the authors seek an answer to the following problematic question: what are the values of the companies operating in the pharmaceutical market and how are they oriented: inward, that is, economic indicators of the company, or outward, where are the benefits of the social context highlighted? Therefore, the purpose of this study is the identification of values of companies operating in the pharmaceutical market, establishing the most frequently published/congruent values, and grouping them according to the chosen classification, to distinguish directions of value orientation. For the purposes of this study, 50 largest pharmaceutical companies operating in the Lithuanian market, generating 80% of all money circulating in the Lithuanian pharmaceutical sector, were selected. After analyzing the websites of the 50 largest companies, 30 of them were selected for further analysis. This study proposes a different approach when after highlighting value groups of pharmaceutical companies, attention is drawn to the directions of declared values. This helps to answer questions about which values are oriented to internal processes of companies and benefits they bring to the organization and which ones, to external entities. Such separation can serve, seeking to more precisely highlight value preferences of organizations in the information flow on their web pages.

An inexhaustible topic of values, not all of which are timely recognized in research. I invite you to read my colleague’s article: doi.org/10.1007/978-... #values #openscience #science #pharmaceuticalcompanies

#trends today for 'pharmaceutical companies' 'fatal overdose' & 'shootings suspect'

Click/Tap below:

www.newsmason.com?query=%22pha...

www.newsmason.com?query=%22fat...

www.newsmason.com?query=%22sho...

#pharmaceuticalcompanies #fataloverdose #shootingssuspect

Doctors’ professional associations, concerned about the potential for conflict of interest, caution their members about their financial ties to pharmaceutical manufacturers. Photo by Armend NIMANI / AFP

Your doctor could be receiving payments from a drug company. Why won’t anyone tell you?

#Canada 🇨🇦 #Cdnpoli #ONpoli #Physicians #Surgeons #Doctors #MedicalDevices #Health #PharmaceuticalCompanies #PublicAccountability #HealthCare

ijb.utoronto.ca/news/your-do...

Big Pharma's Doctor Control - Dr Jen Gunter and Doctor Mike

#pharmaceuticalcompanies #doctors

Companies granted third extension to VPAG 2026 decision deadline – now set for 16 December The ABPI and the government have agreed to a further extension to the deadline by which companies must give notice if they intend to leave the 2024 voluntary scheme for branded medicines pricing, acce...

#ABPI #pharma #pharmaceuticals #PharmaceuticalCompanies #VPAG2026 #UKgovernment #voluntaryschemeforbrandedmedicinespricingaccessandgrowth #VPAGscheme #lifesciencessector #StatutorySchemeforbrandedmedicines #brandedpharmaceuticals #VPAG #VPAG1 #VoluntaryScheme #VoluntarySchemeNews
zurl.co/lJJaE

Pharma says UK is 'tumbling down' rankings for investment The UK is losing out to competitors in attracting investment in R&D, clinical trials, and capital projects, says a report from the ABPI pharma group.

#pharmaceuticals #Pharmainvestment #RandD #clinicaltrials #capitalprojects #innovativenewmedicines #pharmaindustry #ABPI #VPAG #brandedmedicines #pharmaceuticalcompanies #healthcarespending #biotech #pharmaceuticalinnovation #lifesciencespowerhouse #AI #cellandgenetherapies
zurl.co/aDLED

Merck scraps £1bn expansion in the UK over lack of state investment The firm, known as MSD in Europe, said there has been a lack of investment in life sciences.

#pharmaindustry #lifesciences #MSD #Medicine #Pharmaceuticalindustry #UKeconomy #pharmaceuticalcompanies #NHS #NHSmedicinesspending #healthcarespend #ABPI #AstraZeneca #cuttingedgetreatments #Norvartis #DepartmentofIndustryScienceandTechnology #NHSinnovation
www.bbc.co.uk/news/article...

Tough talk from Streeting – but he still needs a deal with big pharma Health secretary calls industry ‘shortsighted’ but there is danger in giving UK better terms than much of rich Europe

#pharma #pharmaceuticals #pharmaindustry #WesStreeting #UK #pharmaceuticalcompanies #priceofprescriptionmedicines #prescriptionmedicines #Pharmaceuicalpricing #ABPI #UKlifesciences #Trump #NHS #voluntarypricingschemes #VPAG #NHSbudget #NICE #lifesciencesstrategy #TrumpTariffs
zurl.co/ARfrH

Why the pharmaceutical industry needs NHS data to develop new medicines To help understand why NHS data is crucial for research, developing innovative, safe, and effective medicines, we have created a publicly accessible case study library.

#ABPI #pharmaceuticalindustry #NHSdata #medicalresearch #healthoutcomes #medicalinformation #UKpatients #anonymisedNHSData #anonymisedrepresentativeNHSpopulationdata #NHSpopulationdata #pharmaceuticalcompanies #NHSdataforresearch #HealthDataResearchService
www.abpi.org.uk/media/blogs/...

Disclosure UK 2024: new record for transparency, with nine in ten healthcare professionals named in database Dr Amit Aggarwal, ABPI Director of Medical Affairs, and Alex Fell, PMCPA Chief Executive, discuss the latest data published on Disclosure UK.

#ABPI #pharmaindustry #DisclosureUK #DisclosureUKPublication #PMCPA #pharmaindustrydatabase #pharmaceuticalcompanies #NHSorganisations #UKhealthcare #HCPs #NHS #NHSEngland #AoMRC #NHS10yearplan #OShaughnessyreview #ABPICode #EFPIA #NHSConfederation
www.abpi.org.uk/media/blogs/...

US drug pricing overhaul: The Inflation Reduction Act (IRA) and the Executive Order (EO) on Most-Favored-Nation (MFN) drug pricing in focus Together, these policies signal a new era of pricing accountability and regulatory oversight, with significant implications for drug development strategies, market access, and patient affordability.

In response to the #IRA and the #EO and their potential impact on revenues, #pharmaceuticalcompanies are exploring various strategies.

pharmaphorum.com/sales-market...

UK doubles statutory payment rate on pharmaceutical sales from July The UK government has doubled the rate that pharmaceutical companies must repay on the sales of newer products to the NHS under the statutory scheme for branded medicines in the second half of 2025, t...

#ABPI #spendingreview #StatutoryScheme #VoluntaryScheme #VPAG #pharmaceuticalsales #UKgovernment #pharmaceuticalcompanies #NHS #brandedmedicines #NHSsales #healthcarebudget #healthcarespending #pharmaindustryinvestment #UK #VPAGreview #lifescienceinvestments
www.abpi.org.uk/media/news/2...

Study says private clinics are selling patient data to big pharma Experts call for updated health privacy laws

#Canadian users of private healthcare clinics - BE AWARE. As reported yesterday by CTV, the #CanadianHealthCoalition also warns that #privateclinics are using and/or #SELLING your private #healthdata to big #pharmaceuticalcompanies.

www.healthcoalition.ca/study-says-p...

Sales Force Automation For Pharma Companies: Why It Matters? Pharma companies can reap many benefits like real-time reporting, monthly sales forecasts and enhanced employee productivity due to Sales Force Automation software.

Pharma CRM (Customer Relationship Management) software is designed specifically for the pharmaceutical industry to manage sales, marketing, and customer interactions. It helps #pharmaceuticalcompanies.
www.saneforce.com/blogs/sales-...

GODDAMN IT!.... I agree with this schmuck. I'm sure he'll have a change of heart when #BigPharma delivers a dump truck full of money to his front door.

#RFKJr #pharmaceutical #PharmaceuticalCompanies

Blood cancer patients face treatment access disparity - PharmaTimes New research highlights NHS approval gap compared to other cancers

#healthinequalities #Bloodcancer #Bloodcancerpatients #Bloodcancertreatment #BloodCancerAlliance #bloodcancertreatments #NICEapproval #pharmaceuticalcompanies #NICEappraisals #patientoutcomes #CARTtherapy #CiltaCel #myeloma #NICEappraisalprocesses #patientaccess
pharmatimes.com/news/blood-c...

Sales Force Automation For Pharma Companies: Why It Matters? Pharma companies can reap many benefits like real-time reporting, monthly sales forecasts and enhanced employee productivity due to Sales Force Automation software.

#PharmaCRM (Customer Relationship Management) is designed to enhance interactions between #pharmaceuticalcompanies & healthcare professionals. Streamlines, marketing, customer service by providing insights into customer behavior, trends, and compliance requirements.
www.saneforce.com/blogs/sales-...

China just cured a patient’s diabetes for the first times. Why haven’t you heard about it? TikTok video by BreakThrough News

Don't forget..
#diabetes has been cured.

But US #PharmaceuticalCompanies stopped American citizens from receiving it so that they could stay sick & die from it, because they would rather kill them & make money then cure them & not.

That's our current US societal status.
www.tiktok.com/t/ZT2Uw27J4/

Sales Force Automation For Pharma Companies: Why It Matters? Pharma companies can reap many benefits like real-time reporting, monthly sales forecasts and enhanced employee productivity due to Sales Force Automation software.

#CRMsoftware for #pharmaceuticalcompanies is designed to address the unique requirements of the industry, such as managing relationships with healthcare providers and ensuring compliance with regulatory standards.
www.saneforce.com/blogs/sales-...

Sales Force Automation For Pharma Companies: Why It Matters? Pharma companies can reap many benefits like real-time reporting, monthly sales forecasts and enhanced employee productivity due to Sales Force Automation software.

#CRMsoftware for #pharmaceuticalcompanies is tailored to address the unique challenges of the industry. It helps streamline processes such as relationship management with healthcare providers, regulatory compliance, and sales performance tracking.
www.saneforce.com/blogs/sales-...

Sales Force Automation For Pharma Companies: Why It Matters? Pharma companies can reap many benefits like real-time reporting, monthly sales forecasts and enhanced employee productivity due to Sales Force Automation software.

For #pharmaceuticalcompanies, top SFA solutions ensure streamlined operations, better decision-making, and improved sales force effectiveness, driving significant growth.
www.saneforce.com/blogs/sales-...

371 BILLION in profits over the past 14 years!?!?! This just in in the #healthinsurance industry. How many billions more to #pharmaceuticalcompanies? At this point American citizens are not customers and patients, we're profit centers for corporations. #MedicareforAll

YouTube Share your videos with friends, family, and the world

Thoughts?

www.youtube.com/live/vvhBxJc...

#children #pharmaceuticalcompanies #schools

Dave Anthony @daveanthony says, "For the rest of my life, I will never forget a 26 year old started a gofundme to get insulin, didn't get the amount he needed and died rationing his not costly medicine. Just before Thanksgiving.

For context: the "not costly" part means that #insulin is not anywhere near as expensive as the #pharmaceuticalCompanies charge for it. Insulin is astronomically #overpriced for a necessary, #lifeSaving #medication

Global pharma sector stares at lack of talent, specific skills: Report - Yes Punjab News Lack of specific skills and talents has been found to be the biggest obstacle for pharmaceutical companies in their digital transformation journey, according to a new report.

Global pharma sector stares at lack of talent, specific skills: Report
yespunjab.com?p=61679

#Pharma #pharmacy #SkillsGap #DigitalSkills #TechTalentShortage #PharmaIndustry #PharmaceuticalCompanies #Talent